New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review

This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical Oncology (ASCO) Annual Meeting, the European Soci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheorghe, Adelina Silvana, Dumitrescu, Elena Adriana, Komporaly, Isabela Anda, Mihăilă, Raluca Ioana, Lungulescu, Cristian Virgil, Stănculeanu, Dana Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027198/
https://www.ncbi.nlm.nih.gov/pubmed/35448205
http://dx.doi.org/10.3390/curroncol29040231
_version_ 1784691301283790848
author Gheorghe, Adelina Silvana
Dumitrescu, Elena Adriana
Komporaly, Isabela Anda
Mihăilă, Raluca Ioana
Lungulescu, Cristian Virgil
Stănculeanu, Dana Lucia
author_facet Gheorghe, Adelina Silvana
Dumitrescu, Elena Adriana
Komporaly, Isabela Anda
Mihăilă, Raluca Ioana
Lungulescu, Cristian Virgil
Stănculeanu, Dana Lucia
author_sort Gheorghe, Adelina Silvana
collection PubMed
description This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical Oncology (ASCO) Annual Meeting, the European Society for Medical Oncology (ESMO) Congress and the Society of Gynecologic Oncology (SGO) Annual Meeting). Despite the underlying existence of the COVID-19 pandemic, the last year has been notable in terms of research, with significant and promising advances in gynecological malignancies. Several major studies reporting the effects of innovative therapies for patients with cervical, endometrial, and ovarian cancers might change the medical practice in the future.
format Online
Article
Text
id pubmed-9027198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90271982022-04-23 New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review Gheorghe, Adelina Silvana Dumitrescu, Elena Adriana Komporaly, Isabela Anda Mihăilă, Raluca Ioana Lungulescu, Cristian Virgil Stănculeanu, Dana Lucia Curr Oncol Review This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical Oncology (ASCO) Annual Meeting, the European Society for Medical Oncology (ESMO) Congress and the Society of Gynecologic Oncology (SGO) Annual Meeting). Despite the underlying existence of the COVID-19 pandemic, the last year has been notable in terms of research, with significant and promising advances in gynecological malignancies. Several major studies reporting the effects of innovative therapies for patients with cervical, endometrial, and ovarian cancers might change the medical practice in the future. MDPI 2022-04-17 /pmc/articles/PMC9027198/ /pubmed/35448205 http://dx.doi.org/10.3390/curroncol29040231 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gheorghe, Adelina Silvana
Dumitrescu, Elena Adriana
Komporaly, Isabela Anda
Mihăilă, Raluca Ioana
Lungulescu, Cristian Virgil
Stănculeanu, Dana Lucia
New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
title New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
title_full New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
title_fullStr New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
title_full_unstemmed New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
title_short New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
title_sort new targeted therapies and combinations of treatments for cervical, endometrial, and ovarian cancers: a year in review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027198/
https://www.ncbi.nlm.nih.gov/pubmed/35448205
http://dx.doi.org/10.3390/curroncol29040231
work_keys_str_mv AT gheorgheadelinasilvana newtargetedtherapiesandcombinationsoftreatmentsforcervicalendometrialandovariancancersayearinreview
AT dumitrescuelenaadriana newtargetedtherapiesandcombinationsoftreatmentsforcervicalendometrialandovariancancersayearinreview
AT komporalyisabelaanda newtargetedtherapiesandcombinationsoftreatmentsforcervicalendometrialandovariancancersayearinreview
AT mihailaralucaioana newtargetedtherapiesandcombinationsoftreatmentsforcervicalendometrialandovariancancersayearinreview
AT lungulescucristianvirgil newtargetedtherapiesandcombinationsoftreatmentsforcervicalendometrialandovariancancersayearinreview
AT stanculeanudanalucia newtargetedtherapiesandcombinationsoftreatmentsforcervicalendometrialandovariancancersayearinreview

Ejemplares similares